Baxter works with FDA to address complaints over device marketing

10/20/2009 | Reuters · Wall Street Journal, The

Baxter International is collaborating with the FDA to address complaints raised in an agency warning letter regarding the marketing of Baxter's Isolex device used in cancer treatment, said company spokeswoman Mavis Prall. In its Sept. 10 letter, the agency warned the company that the product label was misleading.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA